Status:
COMPLETED
Myo vs. Myofascial Injection for Myofascial Trigger Points
Lead Sponsor:
Bozyaka Training and Research Hospital
Conditions:
Myofascial Pain
Myofascial Trigger Point Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.
Detailed Description
This study aims to compare the intramuscular trigger point injection, which is traditionally used in the treatment of myofascial trigger points with the method in which facial layers are also included...
Eligibility Criteria
Inclusion
- Pain in the upper back area
- Detection of active trigger point in upper back muscles (trapezius, levator scapula, rhomboids, supraspinatus and infraspinatus)
- Presence of at least two of the three criteria recommended for the diagnosis of trigger point:
- Taut band
- Hypersensitive point
- Referred pain
- Pain VAS score ≥ 4
- Between the ages of 18-65 -
Exclusion
- Using analgesics or anti-inflammatory medicines.
- Having received physical therapy for the same symptoms in the past 3 months
- Serious psychiatric illness
- Presence of malignancy or infection
- Coagulation disorder
- Pregnancy
- History of operation in the relevant region
- Presence of fibromyalgia syndrome
- History of allergy to local anesthetics
- \-
Key Trial Info
Start Date :
September 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2024
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06029413
Start Date
September 26 2023
End Date
July 25 2024
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Izmir Bozyaka Education and Research Hospital
Izmir, Turkey (Türkiye)